BioCentury
ARTICLE | Financial News

Nanovega receives letter-of-intent for up to $6M

November 21, 2012 1:31 AM UTC

Diagnostic company Nanovega Inc. (San Jose, Calif.) signed a letter-of-intent with Mentor Capital to receive up to $6 million in funding to scale production of Nanovega's ultra-small synthetic antibod...